P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells

Por Delaporte, M, Holl, V, Decoville, T, Penichon, J, Moog, C
Publicado em 2009

P11-16. Transfer of HIV-1 from Langerhans and interstitial dendritic cells to T lymphocytes: protection mediated by antibodies?

Por Peressin, M, Holl, V, Schmidt, S, Decoville, T, Penichon, J, Moog, C
Publicado em 2009

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection

Por Lederle, A, Penichon, J, Decoville, T, Schmidt, S, Moog, C, Holl, V
Publicado em 2009

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes

Por Su, B, Biedma, ME, Lederle, A, Lambotin, M, Moog, C
Publicado em 2012

Studies on the immunological properties of oxysterols: in vivo actions of 7,25-dihydroxycholesterol upon murine peritoneal cells.

Por Moog, C, Ji, Y H, Waltzinger, C, Luu, B, Bischoff, P
Publicado em 1990

Immunogenicity of HIV-1(LAI) gp160 and env peptides in squirrel monkey Saimiri sciureus using alumine and experimental adjuvants

Por PERRAUT, R, CHOUTEAU, P, MOOG, C, BONNEMAINS, B, KIENY, M P
Publicado em 1996

Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.

Por Moog, C, Fleury, H J, Pellegrin, I, Kirn, A, Aubertin, A M
Publicado em 1997

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes

Por Xu, K, Holl, V, Peressin, M, Decoville, T, Schmidt, S, Aubertin, A, Moog, C
Publicado em 2009

Anti-HIV and immune modulating activities of IND02

Por Biedma, ME, Connell, B, Schmidt, S, Lortat-Jacob, H, Moog, C, Prakash, E
Publicado em 2012

P11-20. HIV-1 gp41-specific mucosal IgAs from highly exposed but IgG seronegative women block HIV-1 epithelial transcytosis and neutralize CD4+ cell infection

Por Tudor, D, Derrien, M, Diomede, L, Houimel, M, Drillet, A, Moog, C, Reynes, J, Lopalco, L, Bomsel, M
Publicado em 2009

HIV-1 Replication in Langerhans and Interstitial Dendritic Cells Is Inhibited by Neutralizing and Fc-Mediated Inhibitory Antibodies

Por Peressin, M., Holl, V., Schmidt, S., Decoville, T., Mirisky, D., Lederle, A., Delaporte, M., Xu, K., Aubertin, A. M., Moog, C.
Publicado em 2011

Non-neutralizing IgG anti-PID antibodies decreased viral load following high dose vaginal challenge of non-human primates

Por Moog, C, Dereuddre-Bosquet, N, Biedma, M, Schmidt, S, Decoville, T, Mangeot, I, Zolla-Pazner, S, Vcelar, B, Katinger, D, Holl, V, Le Grand, R
Publicado em 2012

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group

Por Scarlatti, G, Alcami, J, Bongertz, V, Fenyö, E, Heath, A, Heyndrickx, L, Holmes, H, Jansson, M, Lopalco, L, Malnati, M, Montefiori, D, Moog, C, Morris, L, Osmanov, S, Polonis, V, Ramaswamy, M, Sattentau, Q, Schuitemaker, H, Wrin, T
Publicado em 2009

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Por Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R
Publicado em 2012-09-01

Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans

Por Katinger, D, Wagner, A, Luque, I, Crespillo, S, Conejero-Lara, F, Roger, M, Martin, C, Mouz, N, Mourao, S, Farsang, A, Notka, F, Malcolm, K, Bosquet, N, Le Grand, R, Moog, C, Cope, A, Shattock, R, Lewis, DJ, El Habib, R
Publicado em 2012